“…Unfortunately, the further clinical application of iPLNPs was greatly restricted due to the potential risk of the leakage of heavy metal ion from these inorganic nanoparticles [13–14] . On the contrast, organic persistent luminescence nanoparticles (oPLNPs) containing organic chemiluminescence agents [15] (such as peroxalate esters, [16] Schaap's 1,2‐dioxetanes including new generation ones, [17–22] etc) and organic photosensitizers (TPE‐TCy‐VP, [23] TPE‐Ph‐DCM, [24] PFODBT, [25] etc) showed great potential to develop biocompatible afterglow imaging probes due to their facile processability, and flexible surface functionalization [26–28] . Unfortunately, most of the oPLNPs could only be pre‐excited in vitro by visible light, which could not be re‐excited after they got into the bodies [24] .…”